UC a three-time winner of OFC awards
Orthopaedic researcher Chia-Ying “James” Lin wins award for technology that can aid in human tissue growth, repair and prevention
University of Cincinnati researcher and educator Chia-Ying “James” Lin was honored Friday, Oct. 11, as the runner-up for the 2019 Ohio Faculty Council (OFC) Technology Commercialization Award.
Lin, director of the Orthopaedic Research Laboratories in the UC Department of Orthopaedic Surgery and the Mary S. and Joseph S. Stern Jr. Endowed Chair in Musculoskeletal Research, was recognized for his work in developing Amplicore, a biopharmaceutical company specializing in a unique approach for aiding soft skeletal tissue repair. The licensed technology developed by Lin’s company involves a novel pharmaceutical delivery method that has been shown to promote cartilage repair, retard skeletal degenerative diseases and reduce pain and inflammation.
The award went to Ohio State University’s Katrina Cornish for her accomplishments in developing and licensing technology that can extract material from the guayule shrub, which can yield sustainable natural rubber latex products.
Lin says he is honored to be this year's runner-up.
“Receiving the honor is a great encouragement from the state government to recognize our endeavors,” says Lin. “The award also shows the leadership is determined to foster biotechnologies in the state of Ohio and make the place as an emerging cluster for investors who normally only seek opportunities at coastal bio-hubs.”
Lin’s recognition is a reflection of the emphasis UC places on academic excellence and innovation in its strategic direction, Next Lives Here.
“Faculty in the state of Ohio make a profound impact on students and on the health of our economy, and the OFC celebrates the role our excellent faculty play in economic development,” notes Marc Scott, acting OFC chair. “Dr. Cornish’s and Dr. Lin’s work are stellar examples of the impact faculty make across Ohio. Without Ohio’s investment in higher education and commitment to academic freedom, we would have far fewer such examples to celebrate.”
The Ohio Faculty Council, which represents faculty at all four-year public universities in Ohio, launched its annual Technology Commercialization Award in 2016 to recognize a faculty member in the state university system for exceptional research, discoveries and the translation of those discoveries into marketable products and services. Ohio Department of Higher Education Vice Chancellor Mike Duffey presented the awards.
“We expect that Amplicore will be the first of a series of startups that develop from his unique blend of engineering and medical research,” says Lin’s nominator Geoffrey Pinski, the director of Tech Transfer at UC’s Office of Innovation.
This is the second innovation recognition that Lin has received in 2019. MTF Biologics, the world’s largest tissue bank, named Lin this year’s recipient of the J.R. Neff Award. Named in honor of the late orthopaedic surgeon and researcher, James R. Neff, this award goes to an individual whose work in the orthopaedics field “embodies dedication, perseverance and intense curiosity.”
“While treatments for degenerative joint diseases and soft tissue injury still present unmet needs and perhaps the greatest challenges to the orthopaedic medical practice, our new invention to develop novel injectable therapeutics sheds a hope to provide promising alternatives to treat these disorders,” says Lin.
Last year the Ohio Faculty Council recognized Jay Lee, a professor in UC’s College of Engineering and Applied Science, with the Technology Commercialization Award for Lee’s contribution to the field of industrial artificial intelligence. The year prior the recognition went to UC College of Engineering and Applied Science professor Jason Heikenfeld, for developing a suite of new sensor technology in his Novel Devices Lab.Replace with your text
Next Lives Here
Next Lives Here, the University of Cincinnati’s strategic direction, defines our moment and our momentum. More nimble and more robust than a plan, Next Lives Here announces our vision to the world—to lead urban public universities into a new era of innovation, impact, and inclusion.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.